BlueOcean Ventures BOV
First Tokenized Medtech VC Fund. Invest in Europe's Best Ventures
Description
We are the Future of Venture Capital
Revolutionary
One step ahead of the game
We're the first tokenized fund to provide cryptocurrency investors access to a three-year-old medtech fund.
Asset Backed
Existing portfolio
Participate in an already existing portfolio of 5 outstanding ventures from the medical field.
Liquid
VC investment as a tradable asset
We are transforming the highly illiquid Venture Capital asset class into a tradable asset.
Accessible
More payment options
We're providing both cryptocurrency and fiat payment options for investing in our token.
Revolutionary
One step ahead of the game
We're the first tokenized fund to provide cryptocurrency investors access to a three-year-old medtech fund.
Asset Backed
Existing portfolio
Participate in an already existing portfolio of 5 outstanding ventures from the medical field.
Liquid
VC investment as a tradable asset
We are transforming the highly illiquid Venture Capital asset class into a tradable asset.
Accessible
More payment options
We're providing both cryptocurrency and fiat payment options for investing in our token.
General information
Legal
Company name:
SwissVCToken Pte Ltd
Country of incorporation:
Company address:
KYC:
KYC stands for “Know Your Customer”. It’s the process of identity verification of the customer. Each backer is supposed to pass the KYC procedure and provide their credentials in order to participate in this STO.
AML:
The term AML (Anti-Money Laundering) refers to a variety of policies, laws and regulations aimed at combating income generation through fraud.
Token details
Symbol:
BOV
Financial information
Accepts:
BTC, ETH, CHF or US$
Min. investment:
US$ 1,000
Milestones
2008
Launch of BlueOcean Ventures I
2015
Launch of the second fund, BlueOcean Ventures II
2016
BlueOcean Ventures II invests in Ava AG, Rheon Medical SA, and Abionic SA
2017
BlueOcean Ventures II achieves an impressive 48% growth of its portfolio value until end 2017 (audited numbers)
MAY 2018
Set up of Special STO Investment Vehicle in Singapore
JULY 2018
BlueOcean Ventures II invest in Volumina Medical SA and Luciole Medical AG, Start of the presale of the STO
DECEMBER 2018
End of the STO. 100% of the STO net proceeds are invested into BlueOcean Ventures II
BEGINNING OF 2019
BOV token trades on various exchanges and BlueOcean Ventures II has a portfolio of 6 startups
2020/2021
BlueOcean Ventures II has a portfolio of 8 to 12 companies. Initial expected proceed to token holders from first sale of a portfolio company
2025
BlueOcean Ventures II is closed, all remaining assets are distributed to the investors